Disc Medicine, Inc.
IRON
$70.03
$1.502.19%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 13.85% | 19.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.15% | -2.33% | |||
| Operating Income | -5.15% | 2.33% | |||
| Income Before Tax | -4.98% | 2.85% | |||
| Income Tax Expenses | -42.05% | -13.73% | |||
| Earnings from Continuing Operations | -4.91% | 2.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.91% | 2.87% | |||
| EBIT | -5.15% | 2.33% | |||
| EBITDA | -5.16% | 2.34% | |||
| EPS Basic | -2.57% | 9.21% | |||
| Normalized Basic EPS | -4.11% | 10.48% | |||
| EPS Diluted | -2.57% | 9.21% | |||
| Normalized Diluted EPS | -4.11% | 10.48% | |||
| Average Basic Shares Outstanding | 2.28% | 6.98% | |||
| Average Diluted Shares Outstanding | 2.28% | 6.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||